Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
MRSN
Shares outstanding
4,996,999
Price per share
$29.08
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
2,118,875
Total reported value
$61,287,460
% of total 13F portfolios
0%
Share change
-579,869
Value change
-$938,648
Number of holders
46
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
683 Capital Management, LLC 7% +31% $10,215,484 +$2,264,431 351,289 +28% 683 Capital Management, LLC 31 Dec 2025
VANGUARD GROUP INC 4.2% $6,082,136 210,301 The Vanguard Group 31 Dec 2025

As of 31 Dec 2025, 46 institutional investors reported holding 2,118,875 shares of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN). This represents 42% of the company’s total 4,996,999 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) together control 42% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nextech Invest, Ltd. 9.7% 482,689 0% 1.3% $13,964,193
Bain Capital Life Sciences Investors, LLC 6.9% 346,545 0% 0.77% $10,025,547
VANGUARD GROUP INC 4.2% 210,301 -30% 0% $6,084,008
Rock Springs Capital Management LP 3.1% 152,586 0% 0.23% $4,414,313
ACADIAN ASSET MANAGEMENT LLC 2.2% 110,882 -22% 0.01% $3,207,000
Affinity Asset Advisors, LLC 2% 100,000 0.21% $2,893,000
BlackRock, Inc. 1.4% 69,210 -28% 0% $2,002,245
BANK OF AMERICA CORP /DE/ 1.3% 65,749 -0.98% 0% $1,902,119
MILLENNIUM MANAGEMENT LLC 1.3% 63,305 -19% 0% $1,831,414
Groupe la Francaise 1.2% 61,488 0.03% $1,778,848
Rangeley Capital, LLC 1.1% 57,098 1.4% $1,651,845
GABELLI FUNDS LLC 0.95% 47,300 0.01% $1,368,389
GEODE CAPITAL MANAGEMENT, LLC 0.88% 43,920 +5.5% 0% $1,270,972
CREDIT INDUSTRIEL ET COMMERCIAL 0.83% 41,392 0.17% $1,197,471
AQR CAPITAL MANAGEMENT LLC 0.75% 37,264 -20% 0% $1,078,047
MACKENZIE FINANCIAL CORP 0.68% 33,834 -29% 0% $967,437
Yakira Capital Management, Inc. 0.65% 32,663 0.32% $944,940
CITADEL ADVISORS LLC 0.45% 22,493 0% $650,722
STATE STREET CORP 0.39% 19,543 -35% 0% $565,379
MORGAN STANLEY 0.37% 18,496 -62% 0% $535,089
DELTEC ASSET MANAGEMENT LLC 0.36% 18,000 0.09% $520,740
IEQ CAPITAL, LLC 0.26% 12,955 -15% 0% $374,788
XTX Topco Ltd 0.24% 11,948 0.01% $345,656
Point72 Asset Management, L.P. 0.21% 10,364 0% $299,831
GAMCO INVESTORS, INC. ET AL 0.2% 10,000 0% $289,300

Institutional Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,118,875 $61,287,460 -$938,648 $28.93 46
2025 Q3 3,128,210 $24,272,592 +$24,189,765 $7.76 45
2025 Q2 228,339 $68,496 +$68,496 $0.30 2